BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 193 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,104,294 | -52.1% | 461,717 | -36.4% | 0.00% | -60.0% |
Q2 2023 | $23,181,979 | +15.0% | 726,025 | +10.3% | 0.01% | +25.0% |
Q1 2023 | $20,155,860 | -49.4% | 658,258 | -35.4% | 0.00% | -55.6% |
Q4 2022 | $39,829,311 | -20.5% | 1,018,392 | -3.2% | 0.01% | -25.0% |
Q3 2022 | $50,102,000 | +35.7% | 1,051,676 | +10.2% | 0.01% | +50.0% |
Q2 2022 | $36,927,000 | -22.3% | 953,927 | +15.0% | 0.01% | -20.0% |
Q1 2022 | $47,516,000 | -38.8% | 829,247 | -14.9% | 0.01% | -33.3% |
Q4 2021 | $77,619,000 | -14.6% | 974,018 | -6.7% | 0.02% | -21.1% |
Q3 2021 | $90,846,000 | +8.9% | 1,044,082 | +61.1% | 0.02% | 0.0% |
Q2 2021 | $83,410,000 | +41.9% | 648,044 | -11.7% | 0.02% | +26.7% |
Q1 2021 | $58,766,000 | -14.4% | 734,217 | -12.7% | 0.02% | -16.7% |
Q4 2020 | $68,675,000 | +796.1% | 841,193 | +170.2% | 0.02% | +800.0% |
Q3 2020 | $7,664,000 | -13.0% | 311,289 | -1.0% | 0.00% | -33.3% |
Q2 2020 | $8,807,000 | +34.8% | 314,537 | -13.3% | 0.00% | +50.0% |
Q1 2020 | $6,534,000 | – | 362,958 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |